Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
219.80
-0.20 (-0.09%)
At close: Feb 5, 2026
1.10% (1Y)
| Market Cap | 194.84B +1.5% |
| Revenue (ttm) | 81.95B +13.4% |
| Net Income | 25.95B +16.0% |
| EPS | 29.27 +16.0% |
| Shares Out | 886.45M |
| PE Ratio | 7.51 |
| Forward PE | 6.81 |
| Dividend | 12.00 (5.46%) |
| Ex-Dividend Date | Nov 17, 2025 |
| Volume | 598,470 |
| Average Volume | 716,349 |
| Open | 220.00 |
| Previous Close | 220.00 |
| Day's Range | 219.50 - 220.50 |
| 52-Week Range | 198.00 - 234.10 |
| Beta | 0.05 |
| RSI | 73.59 |
| Earnings Date | Jan 29, 2026 |